Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
Longitudinal immune monitoring of patients with resectable esophageal adenocarcinoma treated with Neoadjuvant PD-L1 che…
van den Ende T; Ezdoglian A; Baas LM; Bakker J; Lougheed SM; Harrasser M; Waasdorp C; van Berge Henegouwen MI; Hulshof MCCM; Haj Mohammad N; van Hillegersberg R; Mook S; van der Laken CJ; van Grieken NCT; Derks S; Bijlsma MF; van Laarhoven HWM; de Gruijl TD.
Oncoimmunology
(Unknown)
Published: 2023
Accumulation of tissue-resident natural killer cells, innate lymphoid cells, and CD8<sup>+</sup> T cells towards the ce…
Brownlie D; von Kries A; Valenzano G; Wild N; Yilmaz E; Säfholm J; Al-Ameri M; Alici E; Ljunggren HG; Schliemann I; Aricak O; Haglund de Flon F; Michaëlsson J; Marquardt N.
Oncoimmunology
(Unknown)
Published: 2023
A Chemically Defined TLR3 Agonist with Anticancer Activity.
Le Naour J; Thierry S; Scuderi SA; Boucard-Jourdin M; Liu P; Bonnin M; Pan Y; Perret C; Zhao L; Mao M; Renoux C; Pérez-Lanzón M; Martin B; Kepp O; Kroemer G; Werlé B.
Oncoimmunology
(Unknown)
Published: 2023
Updates on radiotherapy-immunotherapy combinations: Proceedings of 6<sup>th</sup> annual ImmunoRad conference.
Gregucci F; Spada S; Barcellos-Hoff MH; Bhardwaj N; Chan Wah Hak C; Fiorentino A; Guha C; Guzman ML; Harrington K; Herrera FG; Honeychurch J; Hong T; Iturri L; Jaffee E; Karam SD; Knott SRV; Koumenis C; Lyden D; Marciscano AE; Melcher A; Mondini M; Mondino A; Morris ZS; Pitroda S; Quezada SA; Santambrogio L; Shiao S; Stagg J; Telarovic I; Timmerman R; Vozenin MC; Weichselbaum R; Welsh J; Wilkins A; Xu C; Zappasodi R; Zou W; Bobard A; Demaria S; Galluzzi L; Deutsch E; Formenti SC.
Oncoimmunology
(Unknown)
Published: 2023
Reprogramming the immunosuppressive tumor microenvironment results in successful clearance of tumors resistant to radia…
Mukherjee D; Romano E; Walshaw R; Zeef LAH; Banyard A; Kitcatt SJ; Cheadle EJ; Tuomela K; Pendharkar S; Al-Deka A; Salerno B; Raby S; Mills IG; Honeychurch J; Illidge TM.
Oncoimmunology
(Unknown)
Published: 2023
23ME-00610, a genetically informed, first-in-class antibody targeting CD200R1 to enhance antitumor T cell function.
Fenaux J; Fang X; Huang YM; Melero C; Bonnans C; Lowe EL; Palumbo T; Lay C; Yi Z; Zhou A; Poggio M; Chung WJ; Majeed SR; Glatt D; Chen A; Schmidt M; Lee CC.
Oncoimmunology
(Unknown)
Published: 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncology.
Sprooten J; Laureano RS; Vanmeerbeek I; Govaerts J; Naulaerts S; Borras DM; Kinget L; Fucíková J; Špíšek R; Jelínková LP; Kepp O; Kroemer G; Krysko DV; Coosemans A; Vaes RDW; De Ruysscher D; De Vleeschouwer S; Wauters E; Smits E; Tejpar S; Beuselinck B; Hatse S; Wildiers H; Clement PM; Vandenabeele P; Zitvogel L; Garg AD.
Oncoimmunology
(Unknown)
Published: 2023
Increased tryptophan, but not increased glucose metabolism, predict resistance of pembrolizumab in stage III/IV melanom…
Oldan JD; Giglio BC; Smith E; Zhao W; Bouchard DM; Ivanovic M; Lee YZ; Collichio FA; Meyers MO; Wallack DE; Abernethy-Leinwand A; Long PK; Trembath DG; Googe PB; Kowalski MH; Ivanova A; Ezzell JA; Nikolaishvili-Feinberg N; Thomas NE; Wong TZ; Ollila DW; Li Z; Moschos SJ.
Oncoimmunology
(Unknown)
Published: 2023
A PD-L1/EGFR bispecific antibody combines immune checkpoint blockade and direct anti-cancer action for an enhanced anti…
Rubio-Pérez L; Lázaro-Gorines R; Harwood SL; Compte M; Navarro R; Tapia-Galisteo A; Bonet J; Blanco B; Lykkemark S; Ramírez-Fernández Á; Ferreras-Gutiérrez M; Domínguez-Alonso C; Díez-Alonso L; Segura-Tudela A; Hangiu O; Erce-Llamazares A; Blanco FJ; Santos C; Rodríguez-Peralto JL; Sanz L; Álvarez-Vallina L.
Oncoimmunology
(Unknown)
Published: 2023
Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.
Alvarez M; Molina C; Garasa S; Ochoa MC; Rodriguez-Ruiz ME; Gomis G; Cirella A; Olivera I; Glez-Vaz J; Gonzalez-Gomariz J; Luri-Rey C; Azpilikueta A; Bolaños E; Teijeira A; Berraondo P; Quintero M; Melero I.
Oncoimmunology
(Unknown)
Published: 2023